1.
Osteogenesis imperfecta
by Rauch, Frank
The Lancet (British edition), 2004, Vol.363 (9418), p.1377-1385
2.
Intravenous pamidronate treatment of infants with severe osteogenesis imperfecta
by Åström, Eva
Archives of disease in childhood, 2007, Vol.92 (4), p.332-338
3.
Excessive transforming growth factor-β signaling is a common mechanism in osteogenesis imperfecta
by Grafe, Ingo
Nature medicine, 2014, Vol.20 (6), p.670-675
4.
Risedronate in children with osteogenesis imperfecta: a randomised, double-blind, placebo-controlled trial
by Bishop, Nick, Prof
The Lancet (British edition), 2013, Vol.382 (9902), p.1424-1432
5.
Phenotypic Spectrum in Osteogenesis Imperfecta Due to Mutations in TMEM38B: Unraveling a Complex Cellular Defect
by Webb, Emma A
The journal of clinical endocrinology and metabolism, 2017, Vol.102 (6), p.2019-2028
6.
WNT1-associated osteogenesis imperfecta with atrophic frontal lobes and arachnoid cysts
by Kantaputra, Piranit Nik
Journal of human genetics, 2019, Vol.64 (4), p.291-296
7.
The Effect of Whole Body Vibration Training on Bone and Muscle Function in Children With Osteogenesis Imperfecta
by Högler, Wolfgang
The journal of clinical endocrinology and metabolism, 2017, Vol.102 (8), p.2734-2743
8.
Muscle Anatomy and Dynamic Muscle Function in Osteogenesis Imperfecta Type I
by Veilleux, Louis-Nicolas
The journal of clinical endocrinology and metabolism, 2014, Vol.99 (2), p.E356-E362
9.
Macroscopic anisotropic bone material properties in children with severe osteogenesis imperfecta
by Albert, Carolyne
Journal of biomechanics, 2017, Vol.64 (C), p.103-111
10.
Non-Lethal Type VIII Osteogenesis Imperfecta Has Elevated Bone Matrix Mineralization
by Fratzl-Zelman, Nadja
The journal of clinical endocrinology and metabolism, 2016, Vol.101 (9), p.3516-3525
11.
Skeletal effects and functional outcome with olpadronate in children with osteogenesis imperfecta: a 2-year randomised placebo-controlled study
by Sakkers, Ralph
The Lancet (British edition), 2004, Vol.363 (9419), p.1427-1431
12.
Serum 24,25-Dihydroxyvitamin D Concentrations in Osteogenesis Imperfecta: Relationship to Bone Parameters
by Edouard, Thomas
The journal of clinical endocrinology and metabolism, 2012, Vol.97 (4), p.1243-1249
13.
Osteoporosis-Pseudoglioma Syndrome: Three Novel Mutations in the LRP5 Gene and Response to Bisphosphonate Treatment
by Tüysüz, B
Hormone research in paediatrics, 2012, Vol.77 (2), p.115-120
14.
10-m Shuttle Ride Test in Youth With Osteogenesis Imperfecta Who Use Wheelchairs: Feasibility, Reproducibility, and Physiological Responses
by Bongers, Bart C
Physical therapy, 2016, Vol.96 (5), p.679-686
15.
Mechanical properties of physiological and pathological models of collagen peptides investigated via steered molecular dynamics simulations
by Gautieri, Alfonso
Journal of biomechanics, 2008, Vol.41 (14), p.3073-3077
16.
Children and adolescents treated with neridronate for osteogenesis imperfecta show no evidence of any osteonecrosis of the jaw
by MAINES, Evelina
Journal of bone and mineral metabolism, 2012, Vol.30 (4), p.434-438
17.
Anthropometric and Nutritional Parameters in Egyptian Children and Adolescents with Osteogenesis Imperfecta
by Hamza, Rasha Tarif
Hormone research in paediatrics, 2015, Vol.83 (5), p.311-320
18.
Bisphosphonate treatment in the oim mouse model alters bone modeling during growth
by Rao, S.H
Journal of biomechanics, 2008, Vol.41 (16), p.3371-3376
19.
Safety and Efficacy of Intravenous Zoledronic Acid in Paediatric Osteoporosis
by Brown, J.J.
Journal of Pediatric Endocrinology and Metabolism, 2009, Vol.22 (1), p.55-64
20.
An upper extremity inverse dynamics model for pediatric Lofstrand crutch-assisted gait
by Slavens, Brooke A
Journal of biomechanics, 2011, Vol.44 (11), p.2162-2167
